Table 3.
A: 4 Weeks | ||||
---|---|---|---|---|
Experimental Groups | Total n transplants | Total n ESNPCs at end point | Total n without ESNPCs at end point | % with ESNPCs at end point |
10EB no Fibrin | 8 | 6 | 2 | 75% |
10EB + Fibrin | 7 | 6 | 1 | 86% |
10EB + DS + GF | 9 | 9 | 0 | 100% |
10EB + GF no DS | 8 | 8 | 0 | 100% |
Includes rats with over-proliferation | √ | √ | ||
Includes rats with no ESNPCs at end time point | √ |
B. 8 Weeks | ||||
---|---|---|---|---|
Experimental Groups | Total n transplants | Total n ESNPCs at end point | Total n without ESNPCs at end point | % with ESNPCs at end point |
10EB no Fibrin | 10 | 6 | 4 | 60% |
10EB + Fibrin | 9 | 6 | 3 | 67% |
10EB + DS + GF | 10 | 8 | 2 | 80% |
10EB + GF no DS | 8 | 7 | 1 | 88% |
Includes rats with over-proliferation | √ | √ | ||
Includes rats with no ESNPCs at end time point | √ |